While there is so little activity on trade agreements or negotiations and only promises of innovation in trade policy, I’ve been paying closer attention to other things. Demography, of course, and in this case epidemiology.
It took twenty thousand centuries for life-expectancy to double. But it grew by as much again in just one century in Australia. Survival accelerated due to changes in the way we live. Longer, healthier lives in the future, however, will depend on changes to the way we age. There cannot be, a ‘longevity gene’; whatever favours longer life has some other purpose, so manipulation of the complex cellular mechanisms that appear to regulate ageing carries collateral risk. Any advances are still only on the horizon of genetics and biology. But it seems certain the demand is there, driven by the enormous, mostly hidden, economic value of longevity, which is rising rapidly among the new global middle classes in China and India.